Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Corradini
Key Concepts and Critical Issues on Epoetin and Filgrastim Biosimilars. A Position Paper From the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation
Haematologica
Hematology
Allogeneic Transplantation in Hodgkin's Lymphoma After a Failed Autograft: Long Term Outcomes and Graft-Versus-Host Disease Free/Relapse-Free Survival (Grfs)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase Ii Fil-Ptcl13 Study of Romidepsin-Choep Followed by High-Dose Chemotherapy and Transplantation in Untreated Peripheral T-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Donor Lymphocyte Infusions Induce Durable Responses in Patients With Follicular, Mantle and T Cell Lymphomas Relapsing After an Allosct. An Ebmt-LWP Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
BRENTUXIMAB VEDOTIN FOR RELAPSED HODGKIN LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: A RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Intravenous Immunoglobulin Therapy Use in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated With Tisagenlecleucel in the Juliet Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Response Oriented Maintenance Therapy in Advanced Follicular Lymphoma. Results of the Interim Analysis of the Foll12 Trial Conducted by the Fondazione Italiana Linfomi.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Autologous Stem Cell Transplantation as Part of First-Line Therapy in Patients With Peripheral T-Cell Lymphoma: A Multicenter Geltamo/Fil Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
First Salvage Treatment With Bendamustine and Brentuximab Vedotin in Hodgkin Lymphoma: A Phase 2 Study of Fil Onlus
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Second Malignancies and Cardiovascular Diseases in Long-Term Hodgkin Lymphoma Survivors: The Istituto Nazionale Tumori of Milan (INT) Experience
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
1
2
›